Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Articles
Myokardia Inc.
Headquarters:
South San Francisco, CA, United States
Website:
N/A
Year Founded:
2012
Status:
Acquired
BioCentury
|
Mar 10, 2025
Deals
Sun takes shine to Checkpoint in $355M buyout: Deals Report
Plus: Jazz acquires Chimerix for 72% premium, and J&J does not exercise HexaBody Genmab option, Myokardia ends partnership with Fulcrum
Read More
BioCentury
|
Jan 3, 2024
Data Byte
Comparing Cytokinetics’ aficamten with BMS’s Camzyos
Aficamten appears to have slight edge over Camzyos in increasing peak oxygen uptake
Read More
BioCentury
|
Dec 9, 2023
Management Tracks
BMS dealmaker Mily to depart
Plus: CCO Olinger leaving Amylyx and updates from Coherus, Compass and NanoMosaic
Read More
BioCentury
|
Oct 25, 2023
Deals
Oct. 24 Quick Takes: BMS buying back Asia rights to mavacamten from LianBio
Plus: Rampart raises $85M series A for DNA-based therapies and updates from Servier, Novartis, Cargo and more
Read More
BioCentury
|
Feb 25, 2023
Discovery & Translation
De novo enzyme design; plus base editing for hypertrophic cardiomyopathy and more
BioCentury’s roundup of translational news
Read More
BioCentury
|
Feb 2, 2023
Data Byte
Sizing up BMS’s launches as pharma seeks to fill revenue gap
As blockbusters lose patent exclusivity, pharma believes nine-product portfolio has $25B long-term potential
Read More
BioCentury
|
Dec 20, 2022
Management Tracks
MorphoSys’ CFO Lee leaving
Plus: Mestag names Logtenberg as chair and updates from Edgewise, Myriad and Venatorx
Read More
BioCentury
|
Sep 27, 2022
Management Tracks
DEM names Grmusa CEO, Quéva CSO
Plus 5AM adds Arthur Tzianabos, June Lee as venture partners, and updates from Woebot, Flagship Biosciences and Radionetics
Read More
BioCentury
|
Aug 16, 2022
Management Tracks
Simcha hires CEO, expands research agreement
Plus Integra’s Caruso passes away and updates from Ambrx, Cullinan, Zephyr, South Rampart and more
Read More
BioCentury
|
Jul 26, 2022
Management Tracks
Rakhit to succeed Third Rock’s Celniker at Flare
Plus Generate hires Goldman Sachs veteran Jason Silvers as CFO, and updates from HotSpot, Berkeley Lights and more
Read More
Items per page:
10
1 - 10 of 101
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help